#Cannabis #Stock News: Phyto Extractions (CSE: $XTRX.C) (Frankfurt:D2EP) Announces Michael Forbes as New CEO; @adastra_labs
LANGLEY,
BC, May 10, 2021 (investorideas.com
Newswire) Phyto Extractions Inc.
(formerly, Adastra Labs Holdings Ltd.) (CSE:XTRX)(Frankfurt:D2EP) ("Phyto
Extractions" or the "Company") is proud to announce Michael
Forbes Pharm, MBA as its new CEO and director.
Read this news,
featuring XTRX in full at https://www.investorideas.com/CO/XTRX/news/2021/05101New-CEO.asp
Mr.
Forbes comes to Phyto Extractions with a background firmly rooted in medicine,
cannabis production and entrepreneurship. Demonstrating his knowledge and
experience in the cannabis industry, Mr. Forbes has founded five cannabis
medical clinics under the Concord Medical Clinic umbrella, built Clarity
Cannabis and Honeycomb Cannabis to over 10 locations, and also founded the
cannabis licensed production facility, Sitka Weed Works, in Canada.
"I
am honored to have been selected to serve as the new CEO and look forward to
overseeing the execution of the corporate vision of continued leadership in the
recreational cannabis space through the development of brand offerings that
position us as the clear choice in the mind of cannabis consumers now and in
the future," said Michael Forbes, CEO. "My experience in health care,
medicine, business operations and cannabis will be integral to continuing to
strengthen the company's current position and planned expansion into the
burgeoning medical market."
Having
medical experience of over 16 years, Mr. Forbes has also built and operated
pharmacy chains across British Columbia and Alberta, and founded a dozen
medical clinics, including 3 methadone clinics in order to protect the public
from drug diversion and increase accessibility to medicine.
Mr.
Forbes graduated from the University of British Columbia in 2002 with a BSc. in
Pharmaceutical Sciences, also achieving additional certification in Hormone
Restoration, Age Management Medicine, and more recently, Cannabis Plant
Production and Facility Management from Kwantlen Polytechnic University. He was
elected to attend the Ivey School of Business for Canada's Top 40 under 40 in
2017 where he received an honorary MBA.
In
other corporate news, Donald Dinsmore, the Chief Operating Officer of the
Company, was appointed as an additional director to fill the vacancy created by
the prior resignation of Blaine Bailey. Following such changes, the board of
directors consists of Michael Forbes, Donald Dinsmore, Stephen Brohman and George
Routhier.
About Phyto
Extractions
Phyto
Extractions is an agricultural-scale cannabis extraction, distillation and
product manufacturer located in Langley, BC at its co-located Health Canada
Licensed Standard Processing (extraction and products, no cultivation), Sales
(extracts, topicals, and edibles), and R&D through Adastra Labs Inc. and
Analytical Testing Laboratory through Chemia Analytics Inc.
ON
BEHALF OF THE BOARD
PHYTO
EXTRACTIONS INC.
Per:
"Donald Dinsmore"
Donald
Dinsmore
Chief
Operating Officer and Director
Phone:
(778) 715-5011
The
CSE has not reviewed or approved of any contents of this news release.
SOURCE:
Phyto Extractions Inc.
Phyto
Extractions Inc. (CSE:XTRX) (Frankfurt:D2EP) is a featured Cannabis stock on
Investorideas.com
Disclaimer/Disclosure:
Investorideas.com
is a digital publisher of third party sourced news, articles and equity
research as well as creates original content, including video, interviews and
articles. Original content created by investorideas is protected by copyright
laws other than syndication rights. Our site does not make recommendations for
purchases or sale of stocks, services or products. Nothing on our sites should
be construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. Disclosure:
XTRX is a featured cannabis stock on Investorideas.com and the cannabis potcast
effective April 14 More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/
and tickertagstocknews.com
Global
investors must adhere to regulations of each country. Please read
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Get more Cannabis Stock Investor Ideas - news, articles, podcasts and
stock directories
No comments:
Post a Comment